Navigation Links
Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia

BROOMFIELD, Colo., June 11, 2007 /PRNewswire/ -- Accera, Inc. today is presenting data from an open-label extension of its Phase IIb clinical trial of AC-1202 (Ketasyn) in Alzheimer's disease (AD) at the Alzheimer's Association's International Conference on Prevention of Dementia in Washington, D.C. Consistent with the findings of earlier clinical and preclinical studies, AC-1202 was shown to be safe and to significantly improve the memory and cognition of subjects of a particular pharmacogenomic profile.

The randomized, double-blinded, placebo-controlled Phase IIb trial evaluated 152 subjects that had previously been diagnosed with mild to moderate AD at 25 centers across the United States. AC-1202 was administered once daily, and most patients continued to take their other AD drugs such as acetylcholinesterase inhibitors. Following three months of treatment and a two-week washout, eligible subjects were given the opportunity to receive AC- 1202 in a six-month open-label extension study. The main clinical outcome for efficacy was improvement in the AD Assessment Scale-Cognitive (ADAS-Cog) score, which measures memory and other aspects of cognitive performance.

In the double-blind phase of the clinical study the ADAS-Cog scores of the AC-1202-treated ApoE4(-) population improved 3.5 points in twelve weeks (p=0.01) compared to the placebo group, and statistically significant improvement was seen in just 45 days. ApoE4(-) subjects who also exhibited a genetic variation that affects glucose regulation showed a 5-point improvement in ADAS-Cog scores compared to placebo, providing further insight into the disease.

As in the double-blind phase of the study, the most profound effect was seen in subjects not expressing the ApoE4 genotype, a genetic risk factor for AD. ApoE4(-) subjects represent the other half of Alzheimer's patients. ApoE4(-) subjects who started taking AC-1202 on the open-label e
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Accera, Inc. Announces Results of Phase II Study in Alzheimers Disease at American Academy of Neurology Meeting
2. Accera, Inc. to Present Results of Phase II Study in Alzheimers Disease at American Academy of Neurology Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
(Date:11/20/2009)..., NEW YORK, Nov. 20 Reportlinker.c...available in its catalogue. ,, Medical Adhesiv...://www.reportlinker.com/p0164242/Medical-Adhesives...=prnewswire&utm_medium=pr&utm_campaign=prn...ealants is gaining preeminence in medical devices ...
(Date:11/20/2009)...NKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCall/ ... ) today announced the completion of its acquisiti... company that develops and manufactures molecular ...In May 2009, BD and HandyLab announced an exclusiv...lecular assays on the HandyLab Jaguar(TM) platform...
(Date:11/19/2009)...N, France, Nov. 19 In response to ...ngerous and illegal medicines, Operation Pangea II...POL and the World Health Organization,s Internatio... (IMPACT) to highlight the dangers of buying medic... resulted in a series of arrests and the seizure o...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 1Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 2SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 1SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 2SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 3SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 4SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 5Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 1Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 2Enobia Announces Positive Clinical Results With ENB 0040 a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 4996 3
...en abstracts providing new,analyses of data from s...A(R) will be presented at the upcoming 40th Annual...N) in San Francisco on November 2 - 5,2007. Among...nce studies,including MAXIMA, PROTOS, STRIATA and ... AMICUS. Please note all information presented at...
... WASHINGTON, Oct. 16 The following is being,issu...iefing conference call to discuss a new report fro...st for America,s Health (TFAH),"Pandemic Influenza...s gaps,in U.S. preparedness in treating and caring...eak and provides recommendations from AAP and TFAH...
Other Medicine Technology:New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 2New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 3New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 4
(Date:11/20/2009)... , PRINCETON, NJ, Nov. 20 /PRNewswire-FirstC...ay that a Special Meeting of Shareholders will be ...the Meeting is to consider approval of two special...pprove and authorize the sale of all or substantia... the terms provided for in the asset purchase agre...
(Date:11/20/2009)... , MADISON, N.J., Nov. 20 /PRNewswire-Firs...uenza virus may have peaked in late October, but t...source of illness in all age groups, including the...ostics Incorporated (NYSE: DGX ), the world,s le...and services. ,, In its most recent Quest Diag...
(Date:11/20/2009)... , LAS VEGAS, Nov. 20 /PRNewswire-USNewswire/ ...Executive Director of the Nevada Health Care Assoc...(NHCA) commends and thanks Senate Majority Leader ... a step closer toward our goal of protecting every... home care, and preserving the strength and viabil...
(Date:11/20/2009)...Seattle, Washington) November 20, 2009Emergency me... assess an estimated 350,000 cardiac arrests each ...den cardiac arrest survive. Better quality cardio...tal EMS providers may be associated with better pa...ium (ROC) is the largest clinical research network...
(Date:11/20/2009)..., flu activity remains high and is expected to con...ealthDay News) -- Some areas of the United States ...federal health official said Friday, and while the...own from the 46 states reported last week. , "W...activity around the country, but there is still a ...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
...tistry With A Heart, Huckabee Dental,s gift of a f... 13th from 7:30- 4:30, providing free fillings, ex...he first annual Dentistry With A Heart event for D...- The first annual Dentistry with a Heart was a hu...
... Tri-Life Health Treatment Center is one of the mo...the United States. With the opening of this NTR a...to offer a comprehensive program that treats the r...RWEB) February 23, 2009 -- Tri-Life Health , a pr...
...rints Desk, Inc., the content workflow company, to...ne of "KMWorld,s 100 Companies that Matter in..., Los Angeles, Calif. (PRW...s 100 Companies that Matter in Knowledge Managemen...
...nt Obama to Support Effective, Life-saving Program...ns that the administration,s first budget will fla...Alliance is calling on President Obama, Vice Presi...R) and accelerate efforts to ensure every child ar...
...e, UK Cell lifespan is limited by telomeres, DNA...mber of times a cell may be copied. A new study re...m.biologists.org , describes how telomere dysfunct...skin cell telomere dysfunction using a mouse model...
...hen colorectal cancer patients seek out health inf...e more likely to be aware of and receive the lates...pril 1, 2009 issue of CANCER , a peer-reviewed jo...their review, authors led by Stacy Gray, M.D. of t...
Other Medicine News:Health News:Dr Timothy Huckabee Free Day of Dental Care Draws a Crowd 2Health News:Tri-Life Health Offers NTR Addiction Recovery Center in Fort Collins, CO 2Health News:Tri-Life Health Offers NTR Addiction Recovery Center in Fort Collins, CO 3Health News:Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List 2Health News:Reprints Desk Named to "KMWorld 100 Companies that Matter in Knowledge Management" List 3Health News:Global AIDS Alliance Sounds Alarm on Potential Budget Cuts 2Health News:Global AIDS Alliance Sounds Alarm on Potential Budget Cuts 3Health News:Global AIDS Alliance Sounds Alarm on Potential Budget Cuts 4Health News:Patient knowledge of health information influences cancer treatment 2
Uric Acid
... continuous, random access operation, the Elecsys ...lume laboratories that want to maximize productivi...ty, flexibility and Stat capabilities of the Elecs...ging needs of an aggressive laboratory testing env...
Dimension RxL Max w/HM 50/60HZ
SkanWasher 400
Medicine Products: